These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 6604587)
21. Characterization of the epidermal growth factor receptor associated with cytoskeletons of A431 cells. Roy LM; Gittinger CK; Landreth GE J Cell Physiol; 1989 Aug; 140(2):295-304. PubMed ID: 2745564 [TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor receptors in the human glioblastoma cell line SF268 differ from those in epidermoid carcinoma cell line A431. Westphal M; Harsh GR; Rosenblum ML; Hammonds RG Biochem Biophys Res Commun; 1985 Oct; 132(1):284-9. PubMed ID: 2998356 [TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor-induced stimulation of epidermal growth factor-receptor synthesis in human cytotrophoblasts and A431 carcinoma cells. DePalo L; Das M Cancer Res; 1988 Mar; 48(5):1105-9. PubMed ID: 3257711 [TBL] [Abstract][Full Text] [Related]
24. Reciprocal effects of epidermal growth factor and transforming growth factor beta on the anchorage-dependent and -independent growth of A431 epidermoid carcinoma cells. Lee K; Tanaka M; Hatanaka M; Kuze F Exp Cell Res; 1987 Nov; 173(1):156-62. PubMed ID: 3500068 [TBL] [Abstract][Full Text] [Related]
25. The relationship between epidermal growth factor receptors and the terminal differentiation of A431 carcinoma cells. King IC; Sartorelli AC Biochem Biophys Res Commun; 1986 Nov; 140(3):837-43. PubMed ID: 3490853 [TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor treatment of A431 cells alters the binding capacity and electrophoretic mobility of the cytoskeletally associated epidermal growth factor receptor. Roy LM; Gittinger CK; Landreth GE J Cell Physiol; 1991 Jan; 146(1):63-72. PubMed ID: 1990020 [TBL] [Abstract][Full Text] [Related]
27. Cytoskeletal and morphological changes associated with the specific suppression of the epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid carcinoma. Nelson JM; Fry DW Exp Cell Res; 1997 Jun; 233(2):383-90. PubMed ID: 9194500 [TBL] [Abstract][Full Text] [Related]
28. Increased soluble EGF after ischemia is accompanied by a decrease in membrane-associated precursors. Schaudies RP; Johnson JP Am J Physiol; 1993 Mar; 264(3 Pt 2):F523-31. PubMed ID: 8456964 [TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor and gonadotropin-releasing hormone stimulate proliferation of enriched population of gonadotropes. Childs GV; Unabia G Endocrinology; 2001 Feb; 142(2):847-53. PubMed ID: 11159858 [TBL] [Abstract][Full Text] [Related]
30. [In vitro growth and function of neonatal cardiomyocytes in various transcatheter closure device patches]. Sun Y; Zhang RX; Xu ME; Sun KF; Yu B Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):841-4. PubMed ID: 20128386 [TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of a luteinizing hormone-releasing hormone agonist on basal and epidermal growth factor-induced cell proliferation and metastasis-associated properties in human epidermoid carcinoma A431 cells. Huang YT; Hwang JJ; Lee LT; Liebow C; Lee PP; Ke FC; Lo TB; Schally AV; Lee MT Int J Cancer; 2002 Jun; 99(4):505-13. PubMed ID: 11992539 [TBL] [Abstract][Full Text] [Related]
32. Growth characteristics of A431 human epidermoid carcinoma cells in serum-free medium: inhibition by epidermal growth factor. Barnes DW Adv Exp Med Biol; 1984; 172():49-66. PubMed ID: 6610292 [TBL] [Abstract][Full Text] [Related]
33. Rapid increases in the transglutaminase activity of A431 cells following treatment with epidermal growth factor. Dadabay CY; Pike LJ Biochemistry; 1987 Oct; 26(21):6587-91. PubMed ID: 2892526 [TBL] [Abstract][Full Text] [Related]
34. Regulation of protein breakdown by epidermal growth factor in A431 cells. Ballard FJ Exp Cell Res; 1985 Mar; 157(1):172-80. PubMed ID: 3882435 [TBL] [Abstract][Full Text] [Related]
35. Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells. Jakus J; Yeudall WA Oncogene; 1996 Jun; 12(11):2369-76. PubMed ID: 8649777 [TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of chloroform soluble compounds in plasma membranes of human epidermoid carcinoma A431 cells. Brautigan DL; Randazzo P; Shriner C; Fain JN Lipids; 1985 Jul; 20(7):492-5. PubMed ID: 2993780 [TBL] [Abstract][Full Text] [Related]
37. Rapid rounding of human epidermoid carcinoma cells A-431 induced by epidermal growth factor. Chinkers M; McKanna JA; Cohen S J Cell Biol; 1981 Feb; 88(2):422-9. PubMed ID: 6259180 [TBL] [Abstract][Full Text] [Related]
38. Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor. Niedbala MJ; Bajetta S; Carbone R; Sartorelli AC Cancer Commun; 1990; 2(9):317-24. PubMed ID: 2169831 [TBL] [Abstract][Full Text] [Related]
39. Effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on the growth inhibitory and increased phosphatidylinositol (PI) responses induced by epidermal growth factor (EGF) in A431 cells. Smith KB; Losonczy I; Sahai A; Pannerselvam M; Fehnel P; Salomon DS J Cell Physiol; 1983 Oct; 117(1):91-100. PubMed ID: 6311852 [TBL] [Abstract][Full Text] [Related]
40. Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient. Gross ME; Zorbas MA; Danels YJ; Garcia R; Gallick GE; Olive M; Brattain MG; Boman BM; Yeoman LC Cancer Res; 1991 Mar; 51(5):1452-9. PubMed ID: 1847663 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]